| Issue |
Section |
Title |
File |
| Vol 94, No 1 (2022) |
Original articles |
ACTIV SARS-CoV-2 registry (Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients). Assessment of impact of combined original comorbid diseases in patients with COVID-19 on the prognosis |
(Rus)
|
| Vol 93, No 8 (2021) |
Editorial |
Pharmacotherapy of inflammatory bowel diseases: efficacy performance and safety management |
(Rus)
|
| Vol 93, No 8 (2021) |
Original articles |
Prevalence and prognostic value of gastroenterological manifestations of COVID-19: data from the Russian University Clinic |
(Rus)
|
| Vol 93, No 8 (2021) |
Reviews |
Liver cirrosis and complication risk management |
(Rus)
|
| Vol 94, No 8 (2022) |
GUIDELINES |
Epithelial protective therapy in comorbid diseases. Practical Guidelines for Physicians |
(Rus)
|
| Vol 95, No 2 (2023) |
Original articles |
Effectiveness of empirical Helicobacter pylori eradication therapy with furazolidone in Russia: results from the European Registry on Helicobacter pylori Management (Hp-EuReg) |
(Rus)
|
| Vol 95, No 12 (2023) |
Reviews |
Inflammatory bowel diseases: Transformation of representations. A review |
(Rus)
|
| Vol 96, No 2 (2024): Issues of gastroenterology |
Consensuns |
Resolution of the Expert Forum "New therapeutic horizons of NAFLD" |
(Rus)
|
| Vol 96, No 12 (2024): VARIO (РАЗНОЕ) |
Reviews |
Rebamipide: thirty years of experience. A review |
(Rus)
|
| Vol 97, No 2 (2025): Вопросы гастроэнтерологии |
Consensuns |
Russian Cross-disciplinary Consensus on the diagnosis and treatment of spondyloarthritis associated with inflammatory bowel diseases |
(Rus)
|
